CTBP2 and neoplasm: Transcriptomic and metabolomics data of MDA-MB231 cells whose CtBP2 expression has been silenced by shRNA show unique transcriptomic and metabolomic profiles, i.e., the downregulation of genes and metabolites strongly correlated with metabolic and cell biological processes that are associated with uncontrolled tumor growth (Figure 3).